Neurological research and practice最新文献

筛选
英文 中文
Response to the letter to the editor regarding "safety of tenecteplase versus alteplase for intravenous thrombolysis in acute ischemic stroke patients with direct oral anticoagulation". 回复关于“替奈普酶与阿替普酶在急性缺血性卒中患者直接口服抗凝治疗中静脉溶栓的安全性”的致编辑的信。
IF 3.2
Neurological research and practice Pub Date : 2026-02-09 DOI: 10.1186/s42466-026-00459-7
Lena Mers, Stefan T Gerner
{"title":"Response to the letter to the editor regarding \"safety of tenecteplase versus alteplase for intravenous thrombolysis in acute ischemic stroke patients with direct oral anticoagulation\".","authors":"Lena Mers, Stefan T Gerner","doi":"10.1186/s42466-026-00459-7","DOIUrl":"10.1186/s42466-026-00459-7","url":null,"abstract":"","PeriodicalId":94156,"journal":{"name":"Neurological research and practice","volume":"8 1","pages":"8"},"PeriodicalIF":3.2,"publicationDate":"2026-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12888652/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146151639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the editor regarding "Safety of tenecteplase versus alteplase for intravenous thrombolysis in acute ischemic stroke patients with direct oral anticoagulation: experience from a German stroke center" by Mers et al. 关于“替奈普酶与阿替普酶在直接口服抗凝的急性缺血性卒中患者静脉溶栓中的安全性:来自德国卒中中心的经验”,Mers等人致编辑的信。
IF 3.2
Neurological research and practice Pub Date : 2026-02-09 DOI: 10.1186/s42466-026-00458-8
Matija Zupan, Pawel Kermer, Senta Frol
{"title":"Letter to the editor regarding \"Safety of tenecteplase versus alteplase for intravenous thrombolysis in acute ischemic stroke patients with direct oral anticoagulation: experience from a German stroke center\" by Mers et al.","authors":"Matija Zupan, Pawel Kermer, Senta Frol","doi":"10.1186/s42466-026-00458-8","DOIUrl":"10.1186/s42466-026-00458-8","url":null,"abstract":"","PeriodicalId":94156,"journal":{"name":"Neurological research and practice","volume":"8 1","pages":"7"},"PeriodicalIF":3.2,"publicationDate":"2026-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12888728/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146151633","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Consider autoimmune encephalitis in cases of headache, dizziness, and mild pleocytosis following SARS-CoV-2 infection. 考虑在SARS-CoV-2感染后出现头痛、头晕和轻度多细胞症的自身免疫性脑炎。
IF 3.2
Neurological research and practice Pub Date : 2026-02-09 DOI: 10.1186/s42466-026-00469-5
Sinda Zarrouk, Josef Finsterer
{"title":"Consider autoimmune encephalitis in cases of headache, dizziness, and mild pleocytosis following SARS-CoV-2 infection.","authors":"Sinda Zarrouk, Josef Finsterer","doi":"10.1186/s42466-026-00469-5","DOIUrl":"10.1186/s42466-026-00469-5","url":null,"abstract":"","PeriodicalId":94156,"journal":{"name":"Neurological research and practice","volume":"8 1","pages":"10"},"PeriodicalIF":3.2,"publicationDate":"2026-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12888302/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146151657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic performance and safety of the edrophonium test in myasthenia gravis: a retrospective case-control study. 重症肌无力的诊断性能和安全性:一项回顾性病例对照研究。
IF 4
Neurological research and practice Pub Date : 2026-02-09 DOI: 10.1186/s42466-026-00468-6
Omar Keritam, Julia Bettina Kräutler, Diana Gharib, Elnayer Ahmed Jabir, Rosa Weng, Fiona Jäger, Martin Krenn, Anna Paul, Walter Rinner, Hakan Cetin, Fritz Zimprich, Gudrun Zulehner, Jakob Rath
{"title":"Diagnostic performance and safety of the edrophonium test in myasthenia gravis: a retrospective case-control study.","authors":"Omar Keritam, Julia Bettina Kräutler, Diana Gharib, Elnayer Ahmed Jabir, Rosa Weng, Fiona Jäger, Martin Krenn, Anna Paul, Walter Rinner, Hakan Cetin, Fritz Zimprich, Gudrun Zulehner, Jakob Rath","doi":"10.1186/s42466-026-00468-6","DOIUrl":"10.1186/s42466-026-00468-6","url":null,"abstract":"<p><p>BACKGROUND: Myasthenia gravis (MG) is an autoimmune disorder of the neuromuscular junction. The diagnosis typically relies on clinical features, serologic testing, and neurophysiological assessment but provocation tests such as the edrophonium test can provide rapid supportive information; however, data on its diagnostic performance are limited. Thus, we aimed to evaluate the diagnostic performance and safety of the edrophonium test in MG. METHODS: We conducted a retrospective case–control study of patients who underwent an edrophonium test at the Department of Neurology of the Medical University of Vienna between January 1991 and January 2024. We calculated sensitivity, specificity, and likelihood ratios and performed a multivariable logistic regression analysis to identify variables associated with a positive edrophonium test. Additionally, we assessed the safety of the edrophonium test. RESULTS: We included 182 patients with MG (41.2% female; mean age 55.8 years) and 324 controls (55.2% female; mean age 53.6 years). The edrophonium test had a sensitivity of 83.5% and a specificity of 87.7% in diagnosing MG. Patients with a decrement after repetitive nerve stimulation had higher odds of a positive response to the edrophonium test (OR 3.79, 95% CI 1.48–10.33, p = 0.0067), while odds were lower in patients with MuSK-MG compared to patients with AChR-MG (OR 0.08, 95% CI 0.01–0.82, p = 0.0254). Adverse events were reported in 58 patients (11.5%), in most of whom (53 patients, 91.4%) they were mild. CONCLUSIONS: We provide data on the diagnostic performance and safety of the edrophonium test, supporting its use as an adjunctive diagnostic test for the diagnosis of MG. </p>","PeriodicalId":94156,"journal":{"name":"Neurological research and practice","volume":"8 1","pages":"11"},"PeriodicalIF":4.0,"publicationDate":"2026-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12888114/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146151651","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Defining early surgery in traumatic spinal cord injury: admission-based versus injury-based timing. 确定外伤性脊髓损伤的早期手术:基于住院与基于损伤的时机。
IF 3.2
Neurological research and practice Pub Date : 2026-02-09 DOI: 10.1186/s42466-026-00470-y
Audai H Abudayeh, Iakiv Fishchenko
{"title":"Defining early surgery in traumatic spinal cord injury: admission-based versus injury-based timing.","authors":"Audai H Abudayeh, Iakiv Fishchenko","doi":"10.1186/s42466-026-00470-y","DOIUrl":"10.1186/s42466-026-00470-y","url":null,"abstract":"","PeriodicalId":94156,"journal":{"name":"Neurological research and practice","volume":"8 1","pages":"9"},"PeriodicalIF":3.2,"publicationDate":"2026-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12888300/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146151601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Headaches and lymphocytic pleocytosis after COVID-19 require the exclusion of encephalitis. 新冠肺炎后的头痛和淋巴细胞增多症需要排除脑炎。
IF 3.2
Neurological research and practice Pub Date : 2026-02-03 DOI: 10.1186/s42466-026-00461-z
Josef Finsterer
{"title":"Headaches and lymphocytic pleocytosis after COVID-19 require the exclusion of encephalitis.","authors":"Josef Finsterer","doi":"10.1186/s42466-026-00461-z","DOIUrl":"10.1186/s42466-026-00461-z","url":null,"abstract":"","PeriodicalId":94156,"journal":{"name":"Neurological research and practice","volume":"8 1","pages":"1"},"PeriodicalIF":3.2,"publicationDate":"2026-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12870522/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146115441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
AI-assisted hemorrhage detection following endovascular stroke treatment: a retrospective diagnostic accuracy study. 脑卒中治疗后ai辅助出血检测:一项回顾性诊断准确性研究。
IF 4
Neurological research and practice Pub Date : 2026-02-03 DOI: 10.1186/s42466-026-00457-9
Luise Endler, Miar Ouaret, Janos Sebestyen Gellén, Johannes A R Pfaff
{"title":"AI-assisted hemorrhage detection following endovascular stroke treatment: a retrospective diagnostic accuracy study.","authors":"Luise Endler, Miar Ouaret, Janos Sebestyen Gellén, Johannes A R Pfaff","doi":"10.1186/s42466-026-00457-9","DOIUrl":"10.1186/s42466-026-00457-9","url":null,"abstract":"<p><p>BACKGROUND: Antithrombotic therapy is essential for preventing strokes, but its use after reperfusion therapy requires careful monitoring due to the risk of hemorrhagic transformation. Non-contrast-enhanced computed tomography (NCCT) is the standard for detecting intracranial hemorrhages post-stroke. Artificial intelligence may enhance hemorrhage detection and improve patient safety. This study evaluates AI’s sensitivity and specificity in detecting hemorrhagic events in NCCT scans within 48 h after endovascular stroke treatment, compared to standard radiological assessment. METHODS: A retrospective, single-center study was conducted at a European stroke center, including 495 NCCT scans from 425 patients who underwent endovascular stroke treatment between 08/2021 and 06/2024. A CE-marked AI software based on convolutional neural networks (CNN) analyzed the scans independently. The reference standard was assessments of two board-certified neuroradiologists, and AI results were compared with routine radiological reports. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated, and inter-rater reliability was assessed using Cohen’s kappa. RESULTS: The reference standard identified hemorrhages in 197 NCCT scans. The AI system showed sensitivity of 95.9%, specificity of 84.6%, PPV of 80.4%, and NPV of 96.9%. Radiological reports had sensitivity of 91.9%, specificity of 96.3%, PPV of 94.3%, and NPV of 94.7%. Cohen’s kappa was higher for radiological reports (0.886) than AI (0.780), indicating stronger agreement with the reference standard. AI had a higher false-positive rate (15.4%) than radiological reports (3.7%). CONCLUSIONS: AI demonstrated high sensitivity for detecting intracranial hemorrhages but had a higher false-positive rate compared to routine radiological assessment. While AI can aid clinical decision-making, radiologists show superior overall diagnostic accuracy. Further research is needed to explore the impact of AI-assisted decision-making on stroke management and secondary prevention. </p>","PeriodicalId":94156,"journal":{"name":"Neurological research and practice","volume":"8 1","pages":"5"},"PeriodicalIF":4.0,"publicationDate":"2026-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12870412/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146115345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Collaborative neurocardiology board meetings for decision-making in stroke care: a real-world experience. 协作神经心脏病学董事会会议在中风护理决策:现实世界的经验。
IF 4
Neurological research and practice Pub Date : 2026-02-03 DOI: 10.1186/s42466-026-00464-w
V Mafael, T Buck, H Stengl, S Hellwig, M G Klammer, M Endres, M Reinthaler, F Barbieri, H J Audebert, D M Leistner, U Landmesser, W Doehner, C Skurk, J F Scheitz
{"title":"Collaborative neurocardiology board meetings for decision-making in stroke care: a real-world experience.","authors":"V Mafael, T Buck, H Stengl, S Hellwig, M G Klammer, M Endres, M Reinthaler, F Barbieri, H J Audebert, D M Leistner, U Landmesser, W Doehner, C Skurk, J F Scheitz","doi":"10.1186/s42466-026-00464-w","DOIUrl":"10.1186/s42466-026-00464-w","url":null,"abstract":"<p><p>BACKGROUND: Interdisciplinary collaboration between neurologists and cardiologists is needed to provide state-of-the art stroke care and individualized decisions about secondary prevention strategies. This highlights the need to establish working structures for joint decision-making between cardiologists and stroke neurologists. At present, studies describing the real-world decision-making as part of such brain-heart teams are scarce. METHODS: We established a structured heart–brain team approach with monthly virtual neurocardiology board (NCB) meetings within a neurovascular network. We conducted a retrospective analysis of the implementation phase of NCB meetings between 2021 and 2024. We describe the structure of board meetings, patient characteristics and therapeutic and diagnostic recommendations. RESULTS: During the study period, 46 board meetings were held, and 255 patients were discussed. The number of referred patients increased from 32 in 2021 to 89 in 2024. The majority of patients were evaluated for patent foramen ovale (PFO) closure (n = 189, 74.1%, median age 56 years, 59.8% female) and left atrial appendage occlusion (LAAO) (n = 32, 12.5%, median age 83 years, 50% female). Further questions centered around other individual secondary prevention strategies. Among patients referred to discuss PFO closure, closure was not recommended in 43.4% of patients (n = 82), recommended depending on additional diagnostic measures in 13.8% (n = 26), considered optional in 19.6% (n = 37) and clrearly recommended in 23.3% (n = 44). Patients for whom it was not recommended were older, had more cardiovascular risk factors and were less likely to have a large PFO shunt. The main reason for the recommendation against closure was that the PFO was not considered causal for the stroke (80.5%). Among LAAO patients, participation in a randomized controlled trial was recommended in 68.8%. CONCLUSIONS: We successfully established and steadily expanded regular NCB meetings to provide a platform for interdisciplinary exchange and personalized stroke treatment, in particular discussion of indications for interventional procedures against cardiac embolism. Our approach may serve as a blueprint for similar collaborative approaches. Future studies are needed to assess adherence to recommendations and patient outcomes as this study lacks follow-up data. </p>","PeriodicalId":94156,"journal":{"name":"Neurological research and practice","volume":"8 1","pages":"4"},"PeriodicalIF":4.0,"publicationDate":"2026-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12870955/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146115331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the editor regarding "Recent intake of direct oral anticoagulants and acute ischemic stroke: real world data from a comprehensive stroke center" by Pommeranz et al. 关于“近期直接口服抗凝剂和急性缺血性中风的摄入:来自综合中风中心的真实世界数据”,由Pommeranz等人致编辑的信。
IF 3.2
Neurological research and practice Pub Date : 2026-02-03 DOI: 10.1186/s42466-026-00463-x
Matija Zupan, Pawel Kermer, Senta Frol
{"title":"Letter to the editor regarding \"Recent intake of direct oral anticoagulants and acute ischemic stroke: real world data from a comprehensive stroke center\" by Pommeranz et al.","authors":"Matija Zupan, Pawel Kermer, Senta Frol","doi":"10.1186/s42466-026-00463-x","DOIUrl":"10.1186/s42466-026-00463-x","url":null,"abstract":"","PeriodicalId":94156,"journal":{"name":"Neurological research and practice","volume":"8 1","pages":"2"},"PeriodicalIF":3.2,"publicationDate":"2026-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12870436/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146115483","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Functional outcome, five-year survival and burden of disease after size- and location-matched hemorrhagic versus ischemic stroke. 功能结局,大小和位置匹配的出血性卒中与缺血性卒中后的5年生存率和疾病负担。
IF 4
Neurological research and practice Pub Date : 2026-02-03 DOI: 10.1186/s42466-026-00456-w
Stefanie Balk, Teresa Siller, Maximilian I Sprügel, David Haupenthal, Kathrin Kölbl, Stefan Hock, Daniel Heinze, Tobias Engelhorn, Bernd Kallmünzer, Stefan Schwab, Hagen B Huttner, Joji B Kuramatsu, Jochen A Sembill
{"title":"Functional outcome, five-year survival and burden of disease after size- and location-matched hemorrhagic versus ischemic stroke.","authors":"Stefanie Balk, Teresa Siller, Maximilian I Sprügel, David Haupenthal, Kathrin Kölbl, Stefan Hock, Daniel Heinze, Tobias Engelhorn, Bernd Kallmünzer, Stefan Schwab, Hagen B Huttner, Joji B Kuramatsu, Jochen A Sembill","doi":"10.1186/s42466-026-00456-w","DOIUrl":"10.1186/s42466-026-00456-w","url":null,"abstract":"<p><p>BACKGROUND: Worse functional outcome has been reported after hemorrhagic compared to ischemic stroke, yet it remains unclear whether the lesion size, location, or stroke etiology itself results in different degrees of disability. This study compares outcomes in ischemic vs. hemorrhagic stroke patients with matched lesion size and location. METHODS: Data from the longitudinal cohort study on intracerebral hemorrhage (ICH) care (2006–2015) and a retrospective registry on acute ischemic stroke (AIS) (2011–2015), both conducted at the university hospital Erlangen, were used to investigate patients with a single stroke lesion in the middle cerebral artery territory. Patient characteristics, lesion size and affected brain location according to the Alberta Stroke Program Early CT Score (ASPECTS) regions were balanced using propensity score matching. Functional outcomes (ordinal shift of modified Rankin scale (mRS) at 3 months), 5-year survival (Kaplan–Meier, Cox regression), and burden of disease (Disability-Adjusted Life Years [DALYs] = Years of Life Lost [YLL] + Years Lived with Disability [YLD]) were compared. RESULTS: After propensity score matching, we analyzed 194 patients, divided equally into AIS or ICH cases. We observed a shift in mRS distribution towards better functional outcomes in favor of AIS over ICH (OR: 1.69, 95% CI: 1.02–2.79, p = 0.04), especially in younger patients (age < 75 years, OR: 3.23, 95% CI: 1.58–6.59, p < 0.01) and smaller lesion volumes (< 15 mL, OR: 4.48, 95% CI: 1.85–10.89, p < 0.01). The 5-year survival did not differ between groups (log-rank 0.63). Mean number of DALYs was higher following ICH compared to AIS in general (8.39 ± 5.18 vs. 5.90 ± 4.61, p < 0.001) and per milliliter of parenchymal lesion volume (0.31[0.14–0.81] vs. 0.24[0.10–0.41], p = 0.04). The higher number of DALYs is attributable to the higher number of YLDs (ICH, 3.49 ± 3.3 vs. AIS, 2.31 ± 2.86, p < 0.01) and YLLs (ICH, 4.90 ± 3.27 vs. AIS, 3.59 ± 3.08, p < 0.01) in matched patients following ICH compared to AIS. CONCLUSIONS: For stroke lesions of matched size and location, patients with hemorrhagic stroke had worse functional outcome, greater disease burden in total and per ml, yet comparable long-term survival rates compared to those with ischemic stroke. </p>","PeriodicalId":94156,"journal":{"name":"Neurological research and practice","volume":"8 1","pages":"6"},"PeriodicalIF":4.0,"publicationDate":"2026-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12870224/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146115408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书